NIH funds US$600k commercial sale of Permetium scanner to University of Michigan

NIH funds US$600k commercial sale of Permetium scanner to University of Michigan

The influential and respected U.S. National Institutes of Health (NIH) has validated the multiple capabilities of 4DMedical’s Permetium pre-clinical scanner, enabling a $600,000 commercial purchase by the University of Michigan.  In a comprehensive funding submission to the NIH, Michigan recognised Permetium as “the only commercially available device for ultra-high-resolution imaging and quantification of cardiothoracic disease models.”

MEDIA RELEASE _ 4DMedical UMich 15JUN2021